Polyacrylamide-based biocompatible nanoplatform enhances the tumor uptake, PET/fluorescence imaging and anticancer activity of a chlorophyll analog

Theranostics

Volumn 4, Issue 6, 2014, Pages 614-628

  Gupta, Anurag ^a   Wang, Shouyan ^b   Marko, Aimee ^a   Joshi, Penny ^a   Ethirajan, Manivannan ^a   Chen, Yihui ^a   Yao, Rutao ^c   Sajjad, Munawwar ^c   Kopelman, Raoul ^b   Pandey, Ravindra K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Nanoparticles; Photodynamic therapy; Positron imaging tomography; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; CYANINE DYE; METHYL 3 (1' META IODOBENZYLOXY)ETHYL 3 DEVINYLPROPHEOPHORBIDE A I 124; POLYACRYLAMIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CHLOROPHYLL; METHYL 3-(1'-3-IODOBENZYLOXYETHYL)-3-DEVINYLPYROPHEOPHORBIDE-A; NANOPARTICLE; PHOTOSENSITIZING AGENT; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON TUMOR; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FORMULATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; TREATMENT RESPONSE; TUMOR LOCALIZATION; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLONIC NEOPLASMS; DIAGNOSTIC USE; OPTICAL TOMOGRAPHY; PHOTOCHEMOTHERAPY; SCINTISCANNING;

ANIMALS; CHLOROPHYLL; COLONIC NEOPLASMS; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, OPTICAL;

EID: 84902468625     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.8478     Document Type: Article

References (33)

1. Ross B, Rehemtulla A, Koo Y-EL, et al. Photonic and magnetic nanoexplorers for biomedical use: From subcellular imaging to cancer diagnostics and therapy. Proc SPIE. 2004; 5331: 76-83.
2. Kopelman R, Koo Y-EL, Philbert M, et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J Magn Magn Mater. 2005; 293: 404-410.
3. Reddy GR, Bhojani M, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Can Res. 2006; 12(22): 6677-6686.
4. Koo Y-EL, Reddy R, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliver Rev. 2006; 58: 1556-1577.
5. Bhojani MS, et al. Cancer nanotechnology. American Scientific Publishers. 2006.
6. Wang S, Kim G, Lee Y-E, Hah HJ, Ethirajan M, Pandey RK and Kopelman R. Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics - A "see and treat" strategy. ACS Nano. 2012; 6(8): 6843-6851.
7. Wang S, Fan W, Kim G, Hah HJ, Lee Y-E, Kopelman R, Ethirajan M, Gupta A, Goswami LN, Pera P, Morgan J and Pandey RK. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy. Laser Surg Med. 2011; 43: 686-695.
8. Hornyak GL, Tibbals HF, Dutta J, Moore JJ. Introduction to nanoscience & nanotechnology. Boca Raton, Florida, USA: CRC Press; 2009.
9. Condeelis J and Weissleder R. In vivo imaging in cancer. Cold Spring Harb Perspect Biol. 2010; 2: 1-35.
10. Srivatsan A, Jenkins SV, Jeon M, Wu Z, Kim C, Chen J and Pandey R. Gold nanocage-photosensitizer conjugates for dual-model image-guided enhanced photodynamic therapy. Theranostics. 2014; 4(2): 163-174.
11. Kotecha R. and Toledo-Pereyra LH. Beyond the radiograph: radiological advances in surgery. J Invest Surg. 2011; 24: 195-198.
12. Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011; 17: 1680-1684.
13. Welch MJ, Hawker CJ, and Wooley KL. The advantages of nanoparticles for PET. J Nucl Med. 2009; 50: 1743-1746.
14. James NS, Chen Y, Joshi P, Ohulchanskyy TY, Ethirajan M, Henary M, Strekowsk L and Pandey RK. Evaluation of polymethine dyes as potential probes for near infrared fluorescence imaging of tumors: Part-1. Theranostics. 2013; 3(9): 692-702.
15. James NS, Ohulchanskyy TY, Chen Y, Joshi P, Goswami LN and Pandey RK. Comparative tumor imaging and PDT efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes. Theranostics. 2013; 3(9): 703-718.
16. Gupta A and Pandey RK. Supramolecular approach for tumor imaging and photodynamic therapy. In: Schneider HJ, ed. Supramolecular Systems in Biomedical Fields. Cambridge, UK: RSC Publishing; 2013.
17. Burton JB, Johnson M, Sato M, et al. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med. 2008; 14: 882-888.
18. Phelps ME. Molecular imaging with positron emission tomography. Annu Rev Nucl Part S. 2002; 52: 303-338.
19. Yao R, Lecomte R, Crawford ES. Small-animal PET: What is it, and why do we need it? J Nucl Med Technol. 2012; 40: 157-165.
20. Zaidi H and Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys. 2011; 38: 5667-5689.
21. Lovell JF, Jin CS, Huynh E, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater. 2011; 10: 324-332.
22. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CA-Cancer J Clin. 2011; 61: 250-281.
23. Dougherty TJ, Grindey GB, Fiel R, et al. Photoradiation Therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer I. 1975; 55:115-121.
24. Tan IB, Dolivet G, Ceruse P, et al. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study. Head Neck. 2010; 32: 1597-1604.
25. Sajjad M, Bars E and Nabi HA. Optimization of 124I production via 124Te(p,n)124I reaction. Appl Radiat Isot. 2006; 64: 965-970.
26. Ethirajan M, Chen Y, Joshi P, et al. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev. 2011; 40: 340-362.
27. Ethirajan M, Patel NJ and Pandey RK. Porphyrin-based multifunctional agents for tumor-imaging and photodynamic therapy (PDT) in phototherapy, radioimmunotherapy and imaging. In: Kadish KM, Smith KM & Guilard R, ed. Handbook of Porphyrin Science, Vol. 1. Hackensack, New Jersey, USA: World Scientific Publishing; 2010.
28. Pandey RK, James NS, Chen Y, Missert J and Sajjad M. Bifunctional agents for imaging and therapy. In: Gomer CJ, ed. Photodynamic Therapy, Methods and Protocol. New York: Humana Press; 2010.
29. Pandey SK, Gryshuk AL, Sajjad M, et al. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. J Med Chem. 2005; 48: 6286-6295.
30. Pandey SK, Sajjad M, Chen Y, et al. Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I-labeled methyl-3-(1′-iodobenzyloxyethyl) pyropheophorbide-a vs. the corresponding glucose- and galactose-conjugates. J Med Chem. 2009; 52: 445-455.
31. Pandey SK, Sajjad M, Chen Y, et al. Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging (124I-PET) ability. Bioconjugate Chem. 2009; 20:274-282.
32. Srivatsan A, Wang Y, Joshi P, et al. In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a. J Med Chem. 2011; 54: 6859-6873.
33. Gupta A, Wang S, Pera P, et al. Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles. Nanomedicine. 2012; 8: 941-950.